Second-quarter financial results from U.S. pharmaceutical companies gave an early glimpse into life after Zocor, the blockbuster cholesterol drug from Merck that lost patent protection with just a week left in the quarter.
The news was bright for some—companies with newer drugs appear to be well—insulated from generic competition-and far from the dark scenario feared for […]
MANY nations around the world are experiencing an alarming increase in allergic diseases such as eczema and asthma. Perhaps the extent of the problem can be visualised from the statistics revealed at the World Allergy Forum held at the end of the last millennium. It was found that 50% of the world’s teenagers were already […]
MUMBAI: The $8-billion Indian pharmaceuticals market, which is growing at a rate of 9%, has been on the top in the filings of Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs) in the US market. They have lived up to this reputation in the second quarter of 2006 as well. According to a […]
Schering-Plough Corporation (NYSE: SGP - News) today announced a global collaboration with Novartis AG (NYSE: NVS - News) to develop and commercialize a once-daily inhaled fixed-dose combination therapy for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Schering-Plough’s once daily inhaled corticosteroid mometasone, the active ingredient in ASMANEX® and Novartis’ once daily beta2-agonist indacaterol […]
Drugmaker Schering-Plough may have wowed investors with strong second-quarter earnings - but the company has a cholesterol problem.
Schering-Plough, the nation’s No. 9 drugmaker, is heavily dependent on its cholesterol-cutting Vytorin franchise - and the company might be headed for a rough patch if it can’t expand its pipeline with more […]
Breastfeeding babies gives them the best start in life - but too much of a good thing may make them more prone to allergy, a study has found.
Babies fed exclusively on mother’s milk for up to six months are known to be at reduced risk of allergies such as eczema and asthma.
But new research has […]